Bristol-Myers Squibb in Podcasts

company

Bristol-Myers Squibb is a global pharmaceutical company that acquired a biotech company involved in cell therapy.

Mentions Over Time

3 mentions

Wall Street Breakfast

IBM to buy Confluent in further AI push

Pfizer, Bristol-Myers Squibb, and Johnson & Johnson contributed cancer drugs to the catalog.

NPR News Now

NPR News: 12-19-2025 3PM EST

Trump says the companies include Santa Fe, Novartis, Behringer, Gilead, Bristol-Myers Squibb, Genentech, GSK, Merck, and Amgen.

Børsmorgen & Økonominyhetene

Sirkulær RNA, Fredly-favoritt og flat Oslo Børs

Riktig Bristol-Myers Squibb for 1,5 milliarder dollar, også på preklinisk stadion for seks uker siden.